SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-21-000110
Filing Date
2021-07-22
Accepted
2021-07-22 16:50:52
Documents
12
Period of Report
2021-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20210720.htm   iXBRL 8-K 32564
  Complete submission text file 0001367644-21-000110.txt   173933

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20210720.xsd EX-101.SCH 1965
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20210720_lab.xml EX-101.LAB 25154
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20210720_pre.xml EX-101.PRE 13100
5 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20210720_htm.xml XML 11306
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 211108138
SIC: 2834 Pharmaceutical Preparations